Morgan Keegan Initiates CareFusion Coverage: Market Perform, $28 PT

Morgan Keegan initiated CareFusion CFN coverage with a Market Perform rating and $28 price target in a research report published after Tuesday's market close. In the report, Morgan Keegan states, "Although we expect management to execute on its margin expansion plan, macro issues remain a concern. Specifically, we note that the company's exposure to capital equipment and industry price pressure. In addition, we believe that visibility on accelerating sales growth to mid to high-single digits exiting fiscal 2014 is limited at this time." Shares of CareFusion closed Tuesday at $24.02, down 1.80% from Monday's market clsoe.